U.S. Tech Hardware Stock News

If you are wondering whether Cleveland-Cliffs at around US$12.04 is a bargain or a value trap, you are in the right place to size up what the current price actually reflects. The stock has had a mixed run, with a 9.3% decline over the last 7 days and a 2.7% decline over 30 days, yet it still shows a 23.5% return over 1 year and longer term 3 year and 5 year returns of 37.4% and 32.3% declines. Recent attention on Cleveland-Cliffs has centered on its position in the US steel and mining...

If you are wondering whether Weyerhaeuser’s share price really reflects what the business is worth, you are not alone. This article is built to help you answer that question with numbers. Over the last week the stock returned a 2.2% decline, compared with a 4.0% gain over the past 30 days and a 2.6% decline year to date. The 1 year, 3 year and 5 year returns are a 13.5% decline, 18.7% decline and 11.8% decline respectively. Recent coverage around Weyerhaeuser has focused on ongoing interest...

Supportive analyst commentary has put fresh attention on DENTSPLY SIRONA (XRAY) after Barrington Research reiterated an upbeat rating tied to expectations for dental anesthesia market growth and rising procedure volumes, despite recent earnings and guidance pressure. See our latest analysis for DENTSPLY SIRONA. The recent analyst commentary comes after a sharp 7 day share price return of 8.22% and a 30 day share price return of 11.44%. However, the 1 year total shareholder return of negative...

If you have been wondering whether UWM Holdings at around US$4.63 is a bargain or a value trap, you are not alone, and the answer depends on how you look at its fundamentals and price together. The stock has had a mixed run, with a 5.7% return over the last 7 days, a 17.9% decline over 30 days, a 5.0% gain year to date, and an 11.8% decline over the last year, while the 3 year return sits at 48.4% and the 5 year return at a 47.2% decline. Recent coverage around UWM Holdings has focused on...

If you are wondering whether RTX is fairly priced after its recent run, this review will walk through what the numbers currently say about its valuation. Over the last week RTX returned 1.3%, over the past month it returned 8.3%, while the year to date return is a 0.8% decline and the 1 year return is 63.2%, with a very large 5 year gain of 195.5% that may have reshaped expectations. Recent attention on RTX has focused on its role as a major aerospace and defense contractor, as investors...

In recent days, Zoetis has been cited as a key player in veterinary infectious disease diagnostics, as rising zoonotic diseases and the use of artificial intelligence and machine learning increase demand for faster, more accurate testing solutions worldwide. This emphasis on advanced diagnostics underlines how Zoetis is tying its animal health portfolio more closely to data-driven tools that can improve clinical decision-making for both pets and livestock. We’ll now explore how Zoetis’s push...

If you are wondering whether Permian Resources is priced attractively today, or if the easy gains are already behind it, this article walks through the numbers so you can judge the value for yourself. The stock last closed at US$13.50, with a 3.8% decline over the past week, an 8.7% decline over the past month, and a 6.2% decline year to date, while the 3 year return stands at 65.1% and the 5 year return is very large. Recent share price moves sit against a backdrop of ongoing interest in US...

Store closures put tariffs and profitability in focus for Carter's Carter's (CRI) recently outlined plans to close between 100 and 150 low margin or underperforming stores by 2026, citing tariffs as a key factor. This has put its brick and mortar footprint and approach to profitability under closer investor scrutiny. See our latest analysis for Carter's. Carter's recent store closure plan has landed in a mixed share price backdrop, with a 90 day share price return of 17.2% and a 1 year total...

Ferrari stock performance snapshot Ferrari (RACE) has drawn attention after recent share price weakness, with the stock closing at US$366.81 and showing negative returns over the past week, month, past 3 months and year. See our latest analysis for Ferrari. That recent share price softness comes after a weaker patch over several months, with a 1 year total shareholder return of 14.8% decline sitting against a still sizeable 60.3% gain over three years and 71.0% over five years. This suggests...

CareTrust REIT, Inc. recently acquired six skilled nursing facilities in the Mid-Atlantic for approximately US$142 million including transaction costs, adding 532 licensed beds under a long-term triple net lease with inflation-based rent escalators and multiple renewal options. This deal, funded with cash on hand and targeting a stabilized 9% yield, highlights CareTrust’s continuing push to expand its skilled nursing footprint alongside broader portfolio diversification efforts. Now we’ll...

Why Realty Income is on investors’ radar today Realty Income, an S&P 500 real estate company known for its monthly dividend track record, is drawing fresh attention as investors reassess its income profile and current valuation in light of recent share performance. See our latest analysis for Realty Income. At a share price of US$57.35, Realty Income has seen mixed momentum recently, with a 7 day share price return of 1.74% but a 90 day share price return decline of 2.23%. Its 1 year total...

Earlier this week, Wolfe Research analyst Andy Chen downgraded Madrigal Pharmaceuticals from buy to hold, arguing the company’s valuation looks rich relative to its current performance and questioning market expectations for US$6 billion in annual revenue. The shift highlights a growing debate over how much future value is already embedded in Madrigal’s price, despite strong initial uptake of Rezdiffra and a large potential MASH patient pool. We’ll now examine how this valuation-driven...

Dow Inc. announced that long-time Chief Technology Officer A.N. Sreeram will retire in June 2026, with Andre Argenton assuming the newly combined role of Chief Technology and Sustainability Officer from January 1, 2026, while director Rebecca B. Liebert resigned after becoming Chair of Occidental Chemical Corporation’s board. This reshuffle elevates sustainability and safety oversight into Dow’s top technology role, signaling a tighter link between innovation, environmental performance, and...

If you are wondering whether CSX at around US$35.05 is still a solid entry point or if the easy gains are gone, you are in the right place to size up what the current price might be offering you. The stock has seen mixed returns, with a 1 year return of 10.6% but a 7 day decline of 3.3%, a 30 day decline of 3.6% and a year to date decline of 3.4%, which can change how the market views its potential and its risks. Recent headlines around CSX have focused on operational updates and broader...

At CES 2026, Skyworks Solutions introduced the SKY66424-11, a highly integrated Wi-SUN/LoRaWAN RF front-end module for smart home and smart city use, while also showcasing new automotive-grade connectivity and e-mobility solutions. This product set highlights how Skyworks is tightening its focus on connected infrastructure and vehicles, combining RF integration, filtering and compact design to simplify next-generation deployments. Next, we’ll examine how the new SKY66424-11 smart...

Atlassian (TEAM) is back in focus after its Atlassian Williams F1 Team partnered with dashmoto on a limited edition electric scooter, a branding move that arrives alongside a recently reaffirmed positive analyst rating. See our latest analysis for Atlassian. Atlassian's recent branding push with the Williams F1 tie up and reaffirmed positive analyst view comes against a backdrop of mixed performance, with a 90 day share price return of 8.89% and a 1 year total shareholder return decline of...

What sparked fresh interest in IDEAYA Biosciences? IDEAYA Biosciences (IDYA) has come into focus after UBS highlighted its clinical pipeline. The firm pointed in particular to darovasertib and the DLL3 antibody drug conjugate, and also noted GlaxoSmithKline returning the Werner Helicase and Pol Theta programs. See our latest analysis for IDEAYA Biosciences. Those UBS comments and the upcoming J.P. Morgan Healthcare Conference are landing at a time when IDEAYA’s share price has already seen a...

With no single headline event driving attention today, Masimo (MASI) is on investors’ radars as a medical technology maker with mixed return figures, as well as recent revenue and net income trends that invite closer scrutiny. See our latest analysis for Masimo. Masimo’s recent share price moves have been choppy, with a 7-day share price return of 5.4%, a 30-day share price return decline of 2.68%, and a 1-year total shareholder return loss of 18.79%, suggesting that short-term momentum...

If you have been wondering whether Spotify Technology is still fairly priced or starting to look interesting, you are in the right place to size up what the current share price might be giving you. The stock recently closed at US$569.62, with a 1.9% decline over the last 7 days, a 0.5% decline over 30 days, a 0.9% decline year to date, and an 18.7% gain over the last year, alongside a very large return over 3 years and a 64.1% return over 5 years. Recent attention on Spotify has been shaped...

In early January 2026, Valero Energy announced it would idle its Benicia, California refinery while boosting gasoline imports into the San Francisco Bay Area and offering relocation or outplacement support to affected workers under a formal notification process. At the same time, US actions in Venezuela have reopened the prospect of greater access to heavy crude that Valero’s complex Gulf Coast refineries are designed to process, potentially reshaping its feedstock mix and operating...

With no single headline event driving attention today, Costco Wholesale (COST) is back in focus as investors weigh its recent share performance against the company’s scale, profitability, and membership warehouse model. See our latest analysis for Costco Wholesale. The share price has eased back from recent highs, with a 7 day share price return of 2.35% set against a 90 day share price return decline of 6.40%, while the 5 year total shareholder return of 154.20% points to a very different...

American Tower after a tough stretch for the stock American Tower (AMT) has seen its share price under pressure recently, with a 7.5% decline over the past month and an 8.6% drop over the past 3 months. This performance has prompted investors to reassess the REIT’s current setup. See our latest analysis for American Tower. Looking beyond the recent weakness, American Tower’s 1 year total shareholder return of 2.1% decline and 3 year total shareholder return of 17.8% decline suggest fading...

Why Fabrinet Is Drawing Fresh Momentum Interest Recent technical analysis has pushed Fabrinet (FN) into the spotlight, as the stock is flagged for fitting the Minervini Trend Template, with accelerating earnings, sales growth, and rising analyst estimates capturing momentum focused attention. See our latest analysis for Fabrinet. Fabrinet’s share price has been choppy in the short term, with a 1-day share price return of a 1.81% decline and a 30-day share price return of a 4.18% decline, but...

Krystal Biotech (KRYS) is back in focus after the company scheduled a January 8 investor call to share interim data from the highest dose cohort of its Phase 1 CORAL-1 cystic fibrosis study of KB407. See our latest analysis for Krystal Biotech. Krystal Biotech’s recent product news and conference appearances come against a backdrop of a US$246.37 share price, a 30.52% 3 month share price return and a 57.25% 1 year total shareholder return. This suggests momentum has been building as investors...